Clinical Trial Details

NCT ID: NCT00315107
Date Last Changed: May 25, 2006

Overview

Research Study Summary

Patients are needed to participate in a clinical research study evaluating Alesse for the treatment of Acromegaly

Purpose

Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.

To Learn more

Recruitment Details

Phase
2
Gender
Female
Age
18 and up
Overall Status
Recruiting
Lead Sponsor
Université de Montréal
Duration
Facility Type
N/A
Compensation

Eligibility

Female ages 18 Years and up

Inclusion Criteria:

  • Women 18 years and older treated with somatostatin analogs

  • Active acromegaly

Exclusion Criteria:

  • Cardiovascular or cerebrovascular disease

  • Thrombophlebitis or thromboembolism

  • Breast cancer

  • Non-controlled arterial hypertension

  • Smoking

  • Pregnancy or lactation

Site Locations (1)

Country State City Zip Facility and Contact
Canada Quebec Montreal H2L 4M1 CHUM - Notre-Dame Hospital

Omar Serri, MD
Principal Investigator

Contact

Omar SERRI, MD
514-890-8000 ext. 25607
E-mail:

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.